APA (7th ed.) Citation

Emde-Rajaratnam, M., Beck, S., Benes, V., Salwender, H., Bertsch, U., Scheid, C., . . . Hose, D. (2023). RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma. Frontiers in immunology, 14, . https://doi.org/10.3389/fimmu.2023.1286700

Chicago Style (17th ed.) Citation

Emde-Rajaratnam, Martina, et al. "RNA-sequencing Based First Choice of Treatment and Determination of Risk in Multiple Myeloma." Frontiers in Immunology 14 (2023). https://doi.org/10.3389/fimmu.2023.1286700.

MLA (9th ed.) Citation

Emde-Rajaratnam, Martina, et al. "RNA-sequencing Based First Choice of Treatment and Determination of Risk in Multiple Myeloma." Frontiers in Immunology, vol. 14, 2023, https://doi.org/10.3389/fimmu.2023.1286700.